© 2004 Foundation for Promotion of Cancer Research
Cancer Incidence and Incidence Rates in Japan in 1999: Estimates Based on Data from 11 Population-based Cancer Registries
,¶The Research Group for Population-based Cancer Registration in Japan estimated the cancer incidence in Japan in 1999 on the basis of data collected from 11 population-based cancer registries: Miyagi, Yamagata, Chiba, Kanagawa, Niigata, Fukui, Aichi, Shiga, Osaka, Hiroshima City and Nagasaki. The methods of estimation and their limitations have been explained in previous papers (1–3). The number of incidences, crude rates, age-standardized rates and completeness of registration in 1999 are shown in Table 1, and the age-specific number of incidences and crude rates according to sex and primary site are shown in Tables 2 and 3. The number of incidence for 1999 was estimated as 530 000. The time trends of age-standardized incidence rates for the major sites in 1975–99 standardized to the world population are shown in Fig. 1 and those standardized to the 1985 Japanese model population are shown in Fig. 2. The leading site according to the age-standardized incidence rate was stomach for males and breast for females, as shown in Figures 1 and 2.
|
|
|
|
|
The estimated cancer incidence data in Japan by sex, site, 5-year age group and calendar year during the period of 1975–99 are available on a Website (http://www.mc.pref.osaka.jp/ocr/) or by correspondence with the principal investigator of the Research Group (Dr H. Tsukuma).
 |
Acknowledgments |
|---|
 TOP Acknowledgments REFERENCES |
|---|
In 2003, the Research Group conducted the 30th survey on cancer incidence and cancer medical care with the cooperation of the Aichi Cancer Center (Dr T. Kuroishi) and the contribution from 13 cancer registries: Miyagi (Dr D. Shibuya), Yamagata (Dr T. Matsuda), Chiba (Dr H. Mikami), Kanagawa (Dr A. Miyamatsu), Niigata (Dr K. Ogoshi), Fukui (Dr M. Fujita), Aichi (Dr K. Tajima), Shiga (Dr T. Uehata), Osaka (Dr H. Tsukuma), Tottori (Dr T. Kishimoto), Hiroshima City (Dr K. Koyama), Nagasaki (Dr M. Soda) and Okinawa (Dr S. Shimoji). The study was supported by a Grant-in-Aid for Cancer Research from the Japanese Ministry of Health, Labor and Welfare: (14–2).
|
FOOTNOTES |
|---|
+ This report was prepared by Wakiko Ajiki, Hideaki Tsukuma and Akira Oshima, Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
For reprints and all correspondence: Wakiko Ajiki, Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Nakamichi 1–3–3, Higashinari-ku, Osaka 537-8511, Japan. E-mail: ajiki-mi{at}umin.ac.jp
¶ Abbreviations: ICD-10th, International Classification of Diseases, 10th Revision; DCO/I, proportion of cases with the death certificate only to incident cases; I/D, number of incidence/number of deaths; HV/I, proportion of histologically verified cases to incident cases; CIS/carcinoma in situ
|
REFERENCES |
|---|
|
TOPAcknowledgmentsREFERENCES |
|---|
1 The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1988: estimates based on data from ten population-based cancer registries. Jpn J Clin Oncol 1994;24:299–304.
2 The Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan, 1985–89: re-estimation based on data from eight population-based cancer registries. Jpn J Clin Oncol 1999;28:54–67.
3 The Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan. In: Tajima K, Kuroishi T and Oshima A, editors. Cancer Mortality and Morbidity Statistics – Japan and the World – 2004. Gann Monograph on Cancer Research No. 51. Tokyo: Japanese Scientific Societies Press 2004;95–130.
Received March 21, 2004; accepted March 25, 2004
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Eriguchi, H. Oka, T. Mizobuchi, T. Kamimura, K. Sugawara, and A. Harada Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3082 - 3088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kim, C.-L. Sun, B. Mailey, C. Prendergast, A. Artinyan, S. Bhatia, A. Pigazzi, and J. D. I. Ellenhorn Race and ethnicity correlate with survival in patients with gastric adenocarcinoma Ann. Onc., July 21, 2009; (2009) mdp290v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Messina and A. H Wu Perspectives on the soy-breast cancer relation Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1673S - 1679S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ebi, K. Matsuo, N. Sugito, M. Suzuki, H. Osada, K. Tajima, R. Ueda, and T. Takahashi Novel NBS1 Heterozygous Germ Line Mutation Causing MRE11-Binding Domain Loss Predisposes to Common Types of Cancer Cancer Res., December 1, 2007; 67(23): 11158 - 11165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Honjo, J. Ando, T. Tsukioka, H. Morikubo, M. Ichimura, M. Sunagawa, T. Hasegawa, T. Watanabe, T. Kodama, K. Tominaga, et al. Relative and Combined Performance of Mammography and Ultrasonography for Breast Cancer Screening in the General Population: a Pilot Study in Tochigi Prefecture, Japan Jpn. J. Clin. Oncol., September 1, 2007; 37(9): 715 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wakai, C. Date, M. Fukui, K. Tamakoshi, Y. Watanabe, N. Hayakawa, M. Kojima, M. Kawado, K. Suzuki, S. Hashimoto, et al. Dietary Fiber and Risk of Colorectal Cancer in the Japan Collaborative Cohort Study Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 668 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tanaka, F. Uera, H. Tsukuma, A. Ioka, and A. Oshima Distinctive Change in Male Liver Cancer Incidence Rate between the 1970s and 1990s in Japan: Comparison with Japanese-Americans and US Whites Jpn. J. Clin. Oncol., March 1, 2007; 37(3): 193 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hara, K. Honda, M. Shitashige, M. Ono, H. Matsuyama, K. Naito, S. Hirohashi, and T. Yamada Mass Spectrometry Analysis of the Native Protein Complex Containing Actinin-4 in Prostate Cancer Cells Mol. Cell. Proteomics, March 1, 2007; 6(3): 479 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Kamo, S. Kaneko, K. Satoh, H. Yanagihara, S. Mizuno, and T. Sobue A Mathematical Estimation of True Cancer Incidence Using Data from Population-based Cancer Registries Jpn. J. Clin. Oncol., February 1, 2007; 37(2): 150 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nishino, M. Inoue, I. Tsuji, K. Wakai, C. Nagata, T. Mizoue, K. Tanaka, S. Tsugane, and for the Research Group for the Development and Eva Tobacco Smoking and Gastric Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence among the Japanese Population Jpn. J. Clin. Oncol., December 1, 2006; 36(12): 800 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hamashima, T. Sobue, Y. Muramatsu, H. Saito, N. Moriyama, and T. Kakizoe Comparison of Observed and Expected Numbers of Detected Cancers in the Research Center for Cancer Prevention and Screening Program Jpn. J. Clin. Oncol., May 1, 2006; 36(5): 301 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Aoi, H Marusawa, T Sato, T Chiba, and M Maruyama Risk of subsequent development of gastric cancer in patients with previous gastric epithelial neoplasia. Gut, April 1, 2006; 55(4): 588 - 589. [Full Text] [PDF]
|
|
|
|
 |
|
 M Inoue and S Tsugane Epidemiology of gastric cancer in Japan Postgrad. Med. J., July 1, 2005; 81(957): 419 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Michels and W. C. Willett Breast Cancer -- Early Life Matters N. Engl. J. Med., October 14, 2004; 351(16): 1679 - 1681. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||